By systematic comparison with the performanceof DDA, DIA shows higher recovery of glycopeptide toward comprehensiveprofiling on glycopeptides and complex types of glycan structures.The pipeline was applied to establish personalized Hp glycosylationprofiles across patients with HCC and HBV. This evidence concerns the gene HP and hepatocellular carcinoma.